麻豆传媒

Ed Susman

Ed Susman

Authors >

Ed Susman

Ed Susman is a freelance medical writer based in Fort Pierce, Florida, USA. He has been a journalist for more than 40 years, and has specialized in medical and science journalism for more than 25 year. He has written four books including, "Multiple Sclerosis", a book that explains the disease to teenagers. He also has written extensively for United Press International, AIDS (the journal of the International AIDS Society), the Los Angeles Times/Tribune News Service, and for numerous worldwide medical publications, Internet sites and newspapers. He has received numerous news writing awards.

Connect:

email image

Latest from Ed Susman

AHNS over a photo of the Montreal Convention Center in Quebec, Canada.

Primary Surgery vs Radiation in Oropharyngeal Cancer: Does One Come Out a Winner?

Higher short-term dysphagia risk with surgery, but RT/CRT had worse 5-year OS

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

Persistent viral suppression in most patients, even after 8 years

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Can AI Help Determine if Liver Cancer Will Respond to Standard Treatment?

Early model suggests a way to predict progression-free survival

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Fecal Matter Transplant Shows Promise in Cirrhosis

Pilot trial demonstrates that FMT can boost gut health, prevent serious infections

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Novel Agent Leads to Fibrosis Improvement in NASH

Phase IIb ENLIVEN trial saw success with various doses of pegozafermin

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Ukraine's Mobile Medical Teams Duck Rockets

Public health expert describes pivot to provide medical aid in war-torn Ukraine

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

Antiviral Offers 'Glimmer of Hope' in Chronic Hepatitis D

At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48%

EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria

'Game Changer' in NASH: Resmetirom Hits Endpoints in Pivotal Study

Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis

ENDO over a photo of McCormick Place West in Chicago, IL.

Dioxin Exposure Linked to Thyroid Dysfunction

Decreasing animal fat intake might reduce risks

ENDO over a photo of McCormick Place West in Chicago, IL.

Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps

Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient

鈥�

8

鈥�